HIV drug falls short with FDA
From Times Staff and Wire Reports
Pfizer Inc., the world’s biggest drug maker, failed to win U.S. approval for maraviroc, the first new type of medicine in a decade to treat HIV, the virus that causes AIDS.
Pfizer is working on changes the Food and Drug Administration sought on the product’s labeling, the company said Wednesday. Maraviroc is intended for patients who have failed to reduce their levels of HIV with other treatments. If approved, Maraviroc would be an alternative for thousands of Americans with drug-resistant forms of HIV.
